VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56487298  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000042.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q56487298‏
024 ‎‡a  0000-0001-7192-2633‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q56487298‏
100 0 ‎‡a  Jantina de Vries‏ ‎‡c  researcher ORCID: 0000-0001-7192-2633‏ ‎‡9  en‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Jantina de Vries‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Accessing Biospecimens from the H3Africa Consortium.‏
670 ‎‡a  Author's Broad Consent for Genomic Research and Biobanking: Perspectives from Low- and Middle-Income Countries‏
670 ‎‡a  Author's Community engagement in global health research that advances health equity‏
670 ‎‡a  Author's Community engagement strategies for genomic studies in Africa: a review of the literature‏
670 ‎‡a  Author's Consent insufficient for data release‏
670 ‎‡a  Author's Deliberation to Promote Shared Sovereignty in Health Research: Four Questions to Clarify Goals, Methods, and Scope.‏
670 ‎‡a  Author's Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)‏
670 ‎‡a  Author's Equity in international health research collaborations in Africa: Perceptions and expectations of African researchers‏
670 ‎‡a  Author's Ethical and practical issues to consider in the governance of genomic and human research data and data sharing in South Africa: a meeting report‏
670 ‎‡a  Author's Ethical challenges in community engagement practices in research during the COVID-19 pandemic in Africa‏
670 ‎‡a  Author's Ethical Challenges in Contemporary FASD Research and Practice‏
670 ‎‡a  Author's Ethical considerations in forensic genetics research on tissue samples collected post-mortem in Cape Town, South Africa.‏
670 ‎‡a  Author's Ethical issues in genomic research on the African continent: experiences and challenges to ethics review committees‏
670 ‎‡a  Author's Ethical, legal and social issues in the context of the planning stages of the Southern African Human Genome Programme.‏
670 ‎‡a  Author's Exploring researchers' experiences of working with a researcher-driven, population-specific community advisory board in a South African schizophrenia genomics study‏
670 ‎‡a  Author's Genomic sovereignty and the African promise: mining the African genome for the benefit of Africa‏
670 ‎‡a  Author's Global citizen deliberation on genome editing‏
670 ‎‡a  Author's H3Africa: current perspectives.‏
670 ‎‡a  Author's "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa‏
670 ‎‡a  Author's Implications of direct-to-consumer whole-exome sequencing in South Africa.‏
670 ‎‡a  Author's Investigating the potential for ethnic group harm in collaborative genomics research in Africa: is ethnic stigmatisation likely?‏
670 ‎‡a  Author's "It's for a good cause, isn't it?" - Exploring views of South African TB research participants on sample storage and re-use‏
670 ‎‡a  Author's Model framework for governance of genomic research and biobanking in Africa – a content description‏
670 ‎‡a  Author's Policy makers, regulators and researchers’ perspectives on genomics research and the capacity of the National Health Research Act of 2013 to regulate genomics research in Zambia‏
670 ‎‡a  Author's Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk‏
670 ‎‡a  Author's Predictors of consent to cell line creation and immortalisation in a South African schizophrenia genomics study.‏
670 ‎‡a  Author's Providing a policy framework for responsible gene drive research: an analysis of the existing governance landscape and priority areas for further research‏
670 ‎‡a  Author's Psychiatric Genomics: Ethical Implications for Public Health in Lower- and Middle-Income Countries.‏
670 ‎‡a  Author's Regulation of genomic and biobanking research in Africa: a content analysis of ethics guidelines, policies and procedures from 22 African countries‏
670 ‎‡a  Author's Research capacity. Enabling the genomic revolution in Africa‏
670 ‎‡a  Author's Research priorities. ELSI 2.0 for genomics and society‏
670 ‎‡a  Author's Returning incidental findings in African genomics research‏
670 ‎‡a  Author's Seeking consent to genetic and genomic research in a rural Ghanaian setting: A qualitative study of the MalariaGEN experience.‏
670 ‎‡a  Author's The NeuroDev Study: Phenotypic and Genetic Characterization of Neurodevelopmental Disorders in Kenya and South Africa‏
670 ‎‡a  Author's The obesity epidemic: medical and ethical considerations‏
670 ‎‡a  Author's The Path Forward for DNA Data‏
670 ‎‡a  Author's Toward better governance of human genomic data‏
670 ‎‡a  Author's Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon‏
909 ‎‡a  (orcid) 0000000171922633‏ ‎‡9  1‏
912 ‎‡a  researchcapacityenablingthegenomicrevolutioninafrica‏ ‎‡A  Research capacity. Enabling the genomic revolution in Africa‏ ‎‡9  1‏
919 ‎‡a  deliberationtopromotesharedsovereigntyinhealthresearch4questionstoclarifygoalsmethodsandscope‏ ‎‡A  Deliberation to Promote Shared Sovereignty in Health Research: Four Questions to Clarify Goals, Methods, and Scope.‏ ‎‡9  1‏
919 ‎‡a  editorialanideawhosetimehascomeanafricanforesightobservatoryongenomicsmedicineanddataintensiveglobalscience‏ ‎‡A  Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)‏ ‎‡9  1‏
919 ‎‡a  equityininternationalhealthresearchcollaborationsinafricaperceptionsandexpectationsofafricanresearchers‏ ‎‡A  Equity in international health research collaborations in Africa: Perceptions and expectations of African researchers‏ ‎‡9  1‏
919 ‎‡a  ethicalandpracticalissuestoconsiderinthegovernanceofgenomicandhumanresearchdataanddatasharinginsouthafricaameetingreport‏ ‎‡A  Ethical and practical issues to consider in the governance of genomic and human research data and data sharing in South Africa: a meeting report‏ ‎‡9  1‏
919 ‎‡a  genomicsovereigntyandtheafricanpromiseminingtheafricangenomeforthebenefitofafrica‏ ‎‡A  Genomic sovereignty and the African promise: mining the African genome for the benefit of Africa‏ ‎‡9  1‏
919 ‎‡a  globalcitizendeliberationongenomeediting‏ ‎‡A  Global citizen deliberation on genome editing‏ ‎‡9  1‏
919 ‎‡a  h3africacurrentperspectives‏ ‎‡A  H3Africa: current perspectives.‏ ‎‡9  1‏
919 ‎‡a  passedthetestevidenceofdiagnosticmisconceptionintherecruitmentofpopulationcontrolsforanh3africagenomicstudyincapetownsouthafrica‏ ‎‡A  "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa‏ ‎‡9  1‏
919 ‎‡a  implicationsofdirecttoconsumerwholeexomesequencinginsouthafrica‏ ‎‡A  Implications of direct-to-consumer whole-exome sequencing in South Africa.‏ ‎‡9  1‏
919 ‎‡a  investigatingthepotentialforethnicgroupharmincollaborativegenomicsresearchinafricaisethnicstigmatisationlikely‏ ‎‡A  Investigating the potential for ethnic group harm in collaborative genomics research in Africa: is ethnic stigmatisation likely?‏ ‎‡9  1‏
919 ‎‡a  itsforagoodcauseisntitexploringviewsofsouthafricantbresearchparticipantsonsamplestorageandreuse‏ ‎‡A  "It's for a good cause, isn't it?" - Exploring views of South African TB research participants on sample storage and re-use‏ ‎‡9  1‏
919 ‎‡a  modelframeworkforgovernanceofgenomicresearchandbiobankinginafricaacontentdescription‏ ‎‡A  Model framework for governance of genomic research and biobanking in Africa – a content description‏ ‎‡9  1‏
919 ‎‡a  policymakersregulatorsandresearchersperspectivesongenomicsresearchandthecapacityofthenationalhealthresearchactof2013toregulategenomicsresearchinzambia‏ ‎‡A  Policy makers, regulators and researchers’ perspectives on genomics research and the capacity of the National Health Research Act of 2013 to regulate genomics research in Zambia‏ ‎‡9  1‏
919 ‎‡a  potentialuseofclinicalpolygenicriskscoresinpsychiatryethicalimplicationsandcommunicatinghighpolygenicrisk‏ ‎‡A  Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk‏ ‎‡9  1‏
919 ‎‡a  predictorsofconsenttocelllinecreationandimmortalisationinasouthafricanschizophreniagenomicsstudy‏ ‎‡A  Predictors of consent to cell line creation and immortalisation in a South African schizophrenia genomics study.‏ ‎‡9  1‏
919 ‎‡a  providingapolicyframeworkforresponsiblegenedriveresearchananalysisoftheexistinggovernancelandscapeandpriorityareasforfurtherresearch‏ ‎‡A  Providing a policy framework for responsible gene drive research: an analysis of the existing governance landscape and priority areas for further research‏ ‎‡9  1‏
919 ‎‡a  exploringresearchersexperiencesofworkingwitharesearcherdrivenpopulationspecificcommunityadvisoryboardinasouthafricanschizophreniagenomicsstudy‏ ‎‡A  Exploring researchers' experiences of working with a researcher-driven, population-specific community advisory board in a South African schizophrenia genomics study‏ ‎‡9  1‏
919 ‎‡a  psychiatricgenomicsethicalimplicationsforpublichealthinlowerandmiddleincomecountries‏ ‎‡A  Psychiatric Genomics: Ethical Implications for Public Health in Lower- and Middle-Income Countries.‏ ‎‡9  1‏
919 ‎‡a  regulationofgenomicandbiobankingresearchinafricaacontentanalysisofethicsguidelinespoliciesandproceduresfrom22africancountries‏ ‎‡A  Regulation of genomic and biobanking research in Africa: a content analysis of ethics guidelines, policies and procedures from 22 African countries‏ ‎‡9  1‏
919 ‎‡a  towardbettergovernanceofhumangenomicdata‏ ‎‡A  Toward better governance of human genomic data‏ ‎‡9  1‏
919 ‎‡a  ethicallegalandsocialissuesinthecontextoftheplanningstagesofthesouthernafricanhumangenomeprogramme‏ ‎‡A  Ethical, legal and social issues in the context of the planning stages of the Southern African Human Genome Programme.‏ ‎‡9  1‏
919 ‎‡a  wouldyouterminateapregnancyaffectedbysicklecelldiseaseanalysisofviewsofpatientsincameroon‏ ‎‡A  Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon‏ ‎‡9  1‏
919 ‎‡a  ethicalissuesingenomicresearchontheafricancontinentexperiencesandchallengestoethicsreviewcommittees‏ ‎‡A  Ethical issues in genomic research on the African continent: experiences and challenges to ethics review committees‏ ‎‡9  1‏
919 ‎‡a  ethicalconsiderationsinforensicgeneticsresearchontissuesamplescollectedpostmortemincapetownsouthafrica‏ ‎‡A  Ethical considerations in forensic genetics research on tissue samples collected post-mortem in Cape Town, South Africa.‏ ‎‡9  1‏
919 ‎‡a  ethicalchallengesincontemporaryfasdresearchandpractice‏ ‎‡A  Ethical Challenges in Contemporary FASD Research and Practice‏ ‎‡9  1‏
919 ‎‡a  pathforwardfordnadata‏ ‎‡A  The Path Forward for DNA Data‏ ‎‡9  1‏
919 ‎‡a  ethicalchallengesincommunityengagementpracticesinresearchduringthecovid19pandemicinafrica‏ ‎‡A  Ethical challenges in community engagement practices in research during the COVID-19 pandemic in Africa‏ ‎‡9  1‏
919 ‎‡a  researchprioritieselsi20forgenomicsandsociety‏ ‎‡A  Research priorities. ELSI 2.0 for genomics and society‏ ‎‡9  1‏
919 ‎‡a  returningincidentalfindingsinafricangenomicsresearch‏ ‎‡A  Returning incidental findings in African genomics research‏ ‎‡9  1‏
919 ‎‡a  seekingconsenttogeneticandgenomicresearchinaruralghanaiansettingaqualitativestudyofthemalariagenexperience‏ ‎‡A  Seeking consent to genetic and genomic research in a rural Ghanaian setting: A qualitative study of the MalariaGEN experience.‏ ‎‡9  1‏
919 ‎‡a  neurodevstudyphenotypicandgeneticcharacterizationofneurodevelopmentaldisordersinkenyaandsouthafrica‏ ‎‡A  The NeuroDev Study: Phenotypic and Genetic Characterization of Neurodevelopmental Disorders in Kenya and South Africa‏ ‎‡9  1‏
919 ‎‡a  accessingbiospecimensfromtheh3africaconsortium‏ ‎‡A  Accessing Biospecimens from the H3Africa Consortium.‏ ‎‡9  1‏
919 ‎‡a  obesityepidemicmedicalandethicalconsiderations‏ ‎‡A  The obesity epidemic: medical and ethical considerations‏ ‎‡9  1‏
919 ‎‡a  broadconsentforgenomicresearchandbiobankingperspectivesfromlowandmiddleincomecountries‏ ‎‡A  Broad Consent for Genomic Research and Biobanking: Perspectives from Low- and Middle-Income Countries‏ ‎‡9  1‏
919 ‎‡a  communityengagementinglobalhealthresearchthatadvanceshealthequity‏ ‎‡A  Community engagement in global health research that advances health equity‏ ‎‡9  1‏
919 ‎‡a  communityengagementstrategiesforgenomicstudiesinafricaareviewoftheliterature‏ ‎‡A  Community engagement strategies for genomic studies in Africa: a review of the literature‏ ‎‡9  1‏
919 ‎‡a  consentinsufficientfordatarelease‏ ‎‡A  Consent insufficient for data release‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000390681913‏
996 ‎‡2  NTA|071540709‏
996 ‎‡2  NTA|323246486‏
996 ‎‡2  ISNI|0000000020952456‏
996 ‎‡2  LC|n 50013155‏
996 ‎‡2  ISNI|0000000388121837‏
996 ‎‡2  NTA|072909587‏
996 ‎‡2  NTA|074438204‏
996 ‎‡2  ISNI|0000000398600014‏
996 ‎‡2  NTA|124531539‏
996 ‎‡2  ISNI|0000000388198850‏
996 ‎‡2  ISNI|0000000391306357‏
996 ‎‡2  ISNI|000000036892339X‏
996 ‎‡2  RERO|A000048706‏
996 ‎‡2  ISNI|000000039120748X‏
996 ‎‡2  NTA|140891218‏
996 ‎‡2  SUDOC|262233312‏
996 ‎‡2  ISNI|0000000388262162‏
996 ‎‡2  SUDOC|119647710‏
996 ‎‡2  NTA|094968950‏
996 ‎‡2  ISNI|0000000057594605‏
996 ‎‡2  ISNI|0000000389764244‏
996 ‎‡2  ISNI|0000000089993504‏
996 ‎‡2  ISNI|0000000115919640‏
996 ‎‡2  NTA|072698918‏
996 ‎‡2  ISNI|0000000389667751‏
996 ‎‡2  NTA|069183872‏
996 ‎‡2  NTA|162056419‏
996 ‎‡2  NTA|071133518‏
996 ‎‡2  ISNI|0000000387463907‏
996 ‎‡2  ISNI|0000000392091546‏
996 ‎‡2  NTA|261671200‏
996 ‎‡2  NTA|344696189‏
996 ‎‡2  NTA|410813958‏
996 ‎‡2  NTA|17321942X‏
996 ‎‡2  NTA|408760443‏
996 ‎‡2  NTA|137146779‏
996 ‎‡2  ISNI|0000000016115137‏
996 ‎‡2  NTA|073730378‏
996 ‎‡2  NTA|141454954‏
996 ‎‡2  SIMACOB|57076067‏
996 ‎‡2  LC|nr 95010384‏
996 ‎‡2  ISNI|0000000089765579‏
996 ‎‡2  ISNI|0000000393672908‏
996 ‎‡2  ISNI|0000000389850898‏
996 ‎‡2  NTA|073818208‏
996 ‎‡2  NTA|070961891‏
996 ‎‡2  ISNI|0000000389065654‏
996 ‎‡2  ISNI|0000000396523115‏
996 ‎‡2  NTA|06970824X‏
996 ‎‡2  NII|DA13906667‏
996 ‎‡2  NTA|323251676‏
996 ‎‡2  ISNI|0000000459848102‏
996 ‎‡2  NTA|288558928‏
996 ‎‡2  NUKAT|n 95205589‏
996 ‎‡2  NTA|418931100‏
996 ‎‡2  NTA|133263843‏
996 ‎‡2  NTA|073928941‏
996 ‎‡2  NTA|124850391‏
996 ‎‡2  NTA|25895776X‏
996 ‎‡2  ISNI|0000000390529372‏
996 ‎‡2  ISNI|0000000024659599‏
996 ‎‡2  NTA|072055286‏
996 ‎‡2  BIBSYS|90688598‏
996 ‎‡2  NTA|322248639‏
996 ‎‡2  NTA|074711016‏
996 ‎‡2  NTA|298210436‏
996 ‎‡2  LC|n 93117832‏
996 ‎‡2  NUKAT|n 2012150691‏
996 ‎‡2  ISNI|0000000387544109‏
996 ‎‡2  NTA|18040069X‏
996 ‎‡2  NTA|220374880‏
996 ‎‡2  NTA|322249058‏
996 ‎‡2  NTA|288382625‏
996 ‎‡2  ISNI|0000000390082179‏
996 ‎‡2  NTA|305472666‏
996 ‎‡2  ISNI|0000000396245629‏
996 ‎‡2  ISNI|000000039171027X‏
996 ‎‡2  NTA|073525421‏
996 ‎‡2  NTA|091729211‏
996 ‎‡2  NTA|136160859‏
996 ‎‡2  ISNI|000000038950897X‏
996 ‎‡2  DNB|1056703172‏
996 ‎‡2  ISNI|0000000390119648‏
996 ‎‡2  NTA|162882270‏
996 ‎‡2  ISNI|0000000390290701‏
996 ‎‡2  ISNI|0000000388940242‏
996 ‎‡2  NTA|151170401‏
996 ‎‡2  ISNI|0000000368749758‏
996 ‎‡2  NTA|260070327‏
996 ‎‡2  ISNI|0000000394694850‏
996 ‎‡2  NTA|261614916‏
996 ‎‡2  DNB|17251388X‏
996 ‎‡2  BIBSYS|90767336‏
996 ‎‡2  NTA|069867089‏
996 ‎‡2  NTA|067829325‏
996 ‎‡2  PLWABN|9810618464005606‏
996 ‎‡2  ISNI|0000000077587808‏
996 ‎‡2  LC|no2008096894‏
996 ‎‡2  ISNI|0000000387480336‏
996 ‎‡2  ISNI|0000000395191120‏
996 ‎‡2  DNB|1035178745‏
996 ‎‡2  ISNI|0000000387337652‏
996 ‎‡2  ISNI|0000000393863579‏
996 ‎‡2  NKC|jn19990008841‏
996 ‎‡2  NTA|130421316‏
996 ‎‡2  BIBSYS|90214987‏
996 ‎‡2  ISNI|0000000391128781‏
996 ‎‡2  ISNI|0000000395906085‏
996 ‎‡2  NTA|400424045‏
996 ‎‡2  LC|no2022062774‏
996 ‎‡2  NTA|075055961‏
996 ‎‡2  ISNI|0000000391196426‏
996 ‎‡2  NTA|068413858‏
996 ‎‡2  ISNI|0000000392437041‏
996 ‎‡2  NUKAT|n 2022030346‏
996 ‎‡2  NTA|124536549‏
996 ‎‡2  ISNI|0000000390085935‏
996 ‎‡2  NTA|070880204‏
996 ‎‡2  SUDOC|191539074‏
996 ‎‡2  ISNI|0000000389782338‏
996 ‎‡2  NTA|296520497‏
996 ‎‡2  ISNI|0000000394211548‏
996 ‎‡2  NTA|273439162‏
996 ‎‡2  SUDOC|076185699‏
996 ‎‡2  ISNI|0000000392491566‏
996 ‎‡2  NTA|096172975‏
996 ‎‡2  SUDOC|20407942X‏
996 ‎‡2  NTA|261613995‏
996 ‎‡2  BIBSYS|90587337‏
996 ‎‡2  J9U|987007345415705171‏
996 ‎‡2  ISNI|0000000394775917‏
996 ‎‡2  J9U|987007318004905171‏
996 ‎‡2  NTA|07085405X‏
996 ‎‡2  NTA|072975458‏
996 ‎‡2  NTA|133773000‏
996 ‎‡2  ISNI|0000000122762784‏
996 ‎‡2  NTA|252229878‏
996 ‎‡2  NTA|074893017‏
996 ‎‡2  ISNI|0000000395194970‏
996 ‎‡2  ISNI|0000000121393614‏
996 ‎‡2  ISNI|0000000395209036‏
996 ‎‡2  NTA|273406574‏
996 ‎‡2  NTA|295017015‏
996 ‎‡2  ISNI|0000000408739651‏
996 ‎‡2  ISNI|0000000395610006‏
996 ‎‡2  NTA|341039241‏
996 ‎‡2  NTA|074580280‏
996 ‎‡2  ISNI|0000000029321749‏
996 ‎‡2  NTA|068728344‏
996 ‎‡2  NTA|072007524‏
996 ‎‡2  ISNI|0000000080068443‏
996 ‎‡2  NTA|298814536‏
996 ‎‡2  ISNI|0000000392478505‏
996 ‎‡2  LC|n 97077764‏
996 ‎‡2  NTA|241860245‏
996 ‎‡2  NTA|086988875‏
996 ‎‡2  ISNI|000000004550529X‏
996 ‎‡2  NKC|mub20201064281‏
996 ‎‡2  LC|n 78006975‏
996 ‎‡2  NTA|315424036‏
996 ‎‡2  NTA|069332479‏
996 ‎‡2  ISNI|0000000395252026‏
996 ‎‡2  ISNI|000000038467395X‏
996 ‎‡2  NTA|306279975‏
996 ‎‡2  ISNI|0000000397950362‏
996 ‎‡2  NTA|067800351‏
996 ‎‡2  ISNI|0000000390202302‏
996 ‎‡2  ISNI|0000000396141328‏
996 ‎‡2  BNC|981058517648706706‏
996 ‎‡2  ISNI|0000000021961442‏
996 ‎‡2  ISNI|0000000395715289‏
996 ‎‡2  LC|nr 94033184‏
996 ‎‡2  LC|n 82013229‏
996 ‎‡2  NTA|327784881‏
996 ‎‡2  NTA|073527769‏
996 ‎‡2  ISNI|0000000040223162‏
996 ‎‡2  NTA|069727058‏
996 ‎‡2  LC|n 90632665‏
996 ‎‡2  NUKAT|n 2018145760‏
996 ‎‡2  SUDOC|128902167‏
996 ‎‡2  ISNI|0000000395773040‏
996 ‎‡2  NTA|07505583X‏
996 ‎‡2  LC|n 92061328‏
996 ‎‡2  NTA|070235341‏
996 ‎‡2  ISNI|0000000035046288‏
996 ‎‡2  NTA|167716166‏
996 ‎‡2  LC|n 97052842‏
996 ‎‡2  CAOONL|ncf12111227‏
996 ‎‡2  LC|n 82210034‏
996 ‎‡2  DNB|128578254‏
996 ‎‡2  NTA|157824640‏
996 ‎‡2  NTA|073574147‏
996 ‎‡2  NTA|239370384‏
996 ‎‡2  DNB|1159013659‏
996 ‎‡2  NTA|07392587X‏
996 ‎‡2  LC|n 79117361‏
996 ‎‡2  LC|n 82250904‏
996 ‎‡2  ISNI|000000007609469X‏
996 ‎‡2  ISNI|0000000050377296‏
996 ‎‡2  ISNI|0000000394444456‏
996 ‎‡2  NTA|303785616‏
996 ‎‡2  NTA|124491154‏
996 ‎‡2  ISNI|0000000394672854‏
996 ‎‡2  NTA|124036740‏
996 ‎‡2  ISNI|0000000392265278‏
996 ‎‡2  NTA|09650577X‏
996 ‎‡2  NTA|075091798‏
996 ‎‡2  NTA|07430710X‏
996 ‎‡2  SUDOC|24477871X‏
996 ‎‡2  NTA|075055945‏
996 ‎‡2  NTA|380726254‏
996 ‎‡2  ISNI|0000000389416135‏
996 ‎‡2  ISNI|0000000368744690‏
996 ‎‡2  NDL|01060361‏
996 ‎‡2  NTA|124518214‏
996 ‎‡2  ISNI|0000000387354655‏
996 ‎‡2  ISNI|0000000393465298‏
996 ‎‡2  ISNI|0000000388101035‏
996 ‎‡2  ISNI|0000000084156598‏
996 ‎‡2  NTA|410802263‏
996 ‎‡2  ISNI|0000000033649579‏
996 ‎‡2  NTA|34599020X‏
996 ‎‡2  ISNI|0000000394278793‏
996 ‎‡2  NTA|147303370‏
996 ‎‡2  NTA|087181266‏
996 ‎‡2  NTA|130653330‏
996 ‎‡2  NTA|304824070‏
996 ‎‡2  NTA|398129290‏
996 ‎‡2  ISNI|0000000393498460‏
996 ‎‡2  NTA|124539092‏
996 ‎‡2  NTA|296198684‏
996 ‎‡2  ISNI|0000000030752626‏
996 ‎‡2  ISNI|000000004687111X‏
996 ‎‡2  ISNI|0000000367515968‏
996 ‎‡2  NTA|32439571X‏
996 ‎‡2  NTA|105057169‏
996 ‎‡2  ISNI|0000000391432345‏
996 ‎‡2  ISNI|0000000390375932‏
996 ‎‡2  ISNI|0000000390765543‏
996 ‎‡2  DNB|172439396‏
996 ‎‡2  NTA|344713318‏
996 ‎‡2  ISNI|0000000389058585‏
996 ‎‡2  ISNI|000000039457519X‏
996 ‎‡2  ISNI|0000000047365198‏
996 ‎‡2  ISNI|0000000374533769‏
996 ‎‡2  NTA|342087037‏
996 ‎‡2  NTA|074656341‏
996 ‎‡2  NTA|241860288‏
996 ‎‡2  ISNI|0000000393038106‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏